- RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia. Simonin, F., Schmitt, M., Laulin, J.P., Laboureyras, E., Jhamandas, J.H., MacTavish, D., Matifas, A., Mollereau, C., Laurent, P., Parmentier, M., Kieffer, B.L., Bourguignon, J.J., Simonnet, G. Proc. Natl. Acad. Sci. U.S.A. (2006)